Characterization of in vivo expanded OspA-specific human T-cell clones
Váldodahkkit: | Ausubel, L, O'Connor, K, Baecher-Allen, C, Trollmo, C, Kessler, B, Hekking, B, Merritt, D, Meyer, A, Kwok, B, Ploegh, H, Huber, B, Hafler, D |
---|---|
Materiálatiipa: | Journal article |
Almmustuhtton: |
2005
|
Geahča maid
-
Characterization of in vivo expanded OspA-specific human T-cell clones.
Dahkki: Ausubel, L, et al.
Almmustuhtton: (2005) -
The year that shaped the outcome of the OspA vaccine for human Lyme disease
Dahkki: Raymond J. Dattwyler, et al.
Almmustuhtton: (2022-01-01) -
OspA heterogeneity of <it>Borrelia valaisiana </it>confirmed by phenotypic and genotypic analyses
Dahkki: Bretz Anne-Gabrielle, et al.
Almmustuhtton: (2003-06-01) -
Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters
Dahkki: Deborah A Grosenbaugh, et al.
Almmustuhtton: (2018-10-01) -
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
Dahkki: Pär Comstedt, et al.
Almmustuhtton: (2017-01-01)